Your browser doesn't support javascript.
loading
A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.
Dawson, Geraldine; Sun, Jessica M; Baker, Jennifer; Carpenter, Kimberly; Compton, Scott; Deaver, Megan; Franz, Lauren; Heilbron, Nicole; Herold, Brianna; Horrigan, Joseph; Howard, Jill; Kosinski, Andrzej; Major, Samantha; Murias, Michael; Page, Kristin; Prasad, Vinod K; Sabatos-DeVito, Maura; Sanfilippo, Fred; Sikich, Linmarie; Simmons, Ryan; Song, Allen; Vermeer, Saritha; Waters-Pick, Barbara; Troy, Jesse; Kurtzberg, Joanne.
Afiliação
  • Dawson G; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC. Electronic address: geraldine.dawson@duke.edu.
  • Sun JM; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Baker J; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Carpenter K; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Compton S; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Deaver M; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Franz L; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Heilbron N; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Herold B; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Horrigan J; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Howard J; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Kosinski A; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Major S; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Murias M; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Page K; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Prasad VK; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Sabatos-DeVito M; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Sanfilippo F; Emory University School of Medicine, Atlanta, GA.
  • Sikich L; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Simmons R; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Song A; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC; Duke Brain Imaging and Analysis Center, Duke University School of Medicine, Durham, NC.
  • Vermeer S; Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC.
  • Waters-Pick B; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Troy J; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
  • Kurtzberg J; Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, NC.
J Pediatr ; 222: 164-173.e5, 2020 07.
Article em En | MEDLINE | ID: mdl-32444220
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Comunicação / Sangue Fetal / Transtorno do Espectro Autista Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Comunicação / Sangue Fetal / Transtorno do Espectro Autista Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article